1. Fernstrom JD, Faller DV. Neutral amino acids in the brain: changes in response to food ingestion. J Neurochem 1978;30:1531-1538. PMID:
670995.
2. Fernstrom JD. Dietary precursors and brain neurotransmitter formation. Annu Rev Med 1981;32:413-425. PMID:
6111981.
3. Maycox PR, Hell JW, Jahn R. Amino acid neurotransmission: spotlight on synaptic vesicles. Trends Neurosci 1990;13:83-87. PMID:
1691873.
4. Tortorella A, Monteleone P, Fabrazzo M, Viggiano A, De Luca L, Maj M. Plasma concentrations of amino acids in chronic schizophrenics treated with clozapine. Neuropsychobiology 2001;44:167-171. PMID:
11702015.
5. Meltzer HY. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. . Psychopharmacology (Berl) 1989;99(Suppl):S18-S27. PMID:
2682729.
6. Rao ML, Gross G, Strebel B, Bräunig P, Huber G, Klosterkötter J. Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects. Psychiatry Res 1990;34:243-257. PMID:
1981623.
7. Goff DC, Wine L. Glutamate in schizophrenia: clinical and research implications. Schizophr Res 1997;27:157-168. PMID:
9416645.
8. Alfredsson G, Wiesel FA. Relationships between clinical effects and monoamine metabolites and amino acids in sulpiride-treated schizophrenic patients. Psychopharmacology (Berl) 1990;101:324-331. PMID:
2362952.
9. Waziri R, Wilcox J, Sherman AD, Mott J. Serine metabolism and psychosis. Psychiatry Res 1984;12:121-136. PMID:
6147868.
10. Waziri R, Mott J. Drug effects on serine metabolism in psychiatric patients. Psychiatry Res 1986;18:119-126. PMID:
2873604.
11. Macciardi F, Lucca A, Catalano M, Marino C, Zanardi R, Smeraldi E. Amino acid patterns in schizophrenia: some new findings. Psychiatry Res 1990;32:63-70. PMID:
2161549.
12. Perry TL, Hansen S. Interconversion of serine and glycine is normal in psychotic patients. Psychiatry Res 1985;15:109-113. PMID:
3929292.
13. Carl GF, Brogan MP, Young BK. Is plasma serine a marker for psychosis? Biol Psychiatry 1992;31:1130-1135. PMID:
1525276.
14. Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-796. PMID:
3046553.
15. Monda M, Viggiano A, Sullo A, De Luca V. Nitric oxide reduces hypophagia induced by threonine free diet in the rat. Brain Res 1998;808:129-133. PMID:
9767148.
16. Alfredsson G, Wiesel FA, Lindberg M. Glutamate and glutamine in cerebrospinal fluid and serum from healthy volunteers-analytical aspects. J Chromatogr 1988;424:378-384. PMID:
3372631.
17. Perry TL, Wright JM, Hansen S. Hyperasparaginemia in a schizophrenic patient. Biol Psychiatry 1983;18:89-97. PMID:
6830927.
18. Alfredsson G, Wiesel FA. Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment. Psychopharmacology (Berl) 1989;99:322-327. PMID:
2480613.
19. Tomiya M, Fukushima T, Watanabe H, Fukami G, Fujisaki M, Iyo M, et al. Alterations in serum amino acid concentrations in male and female schizophrenic patients. Clin Chim Acta 2007;380:186-190. PMID:
17367771.
20. Evins AE, Amico ET, Shih V, Goff DC. Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics. J Neural Transm 1997;104:761-766. PMID:
9444574.
21. Goff DC, Hennen J, Lyoo IK, Tsai G, Wald LL, Evins AE, et al. Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine. Biol Psychiatry 2002;51:493-497. PMID:
11922885.
22. Maeshima H, Ohnuma T, Sakai Y, Shibata N, Baba H, Ihara H, et al. Increased plasma glutamate by antipsychotic medication and its relationship to glutaminase 1 and 2 genotypes in schizophrenia-Juntendo University Schizophrenia Projects (JUSP). Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1410-1418. PMID:
17669570.
23. Shulman Y, Grant S, Seres P, Hanstock C, Baker G, Tibbo P. The relation between peripheral and central glutamate and glutamine in healthy male volunteers. J Psychiatry Neurosci 2006;31:406-410. PMID:
17136218.
24. McGale EH, Pye IF, Stonier C, Hutchinson EC, Aber GM. Studies of the inter-relationship between cerebrospinal fluid and plasma amino acid concentrations in normal individuals. J Neurochem 1977;29:291-297. PMID:
886334.
25. Baruah S, Waziri R, Hegwood TS, Mallis LM. Plasma serine in schizophrenics and controls measured by gas chromatography-mass spectrometry. Psychiatry Res 1991;37:261-270. PMID:
1679949.
26. Jacquet H, Demily C, Houy E, Hecketsweiler B, Bou J, Raux G, et al. Hyperprolinemia is a risk factor for schizoaffective disorder. Mol Psychiatry 2005;10:479-485. PMID:
15494707.
27. Raux G, Bumsel E, Hecketsweiler B, van Amelsvoort T, Zinkstok J, Manouvrier-Hanu S, et al. Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Hum Mol Genet 2007;16:83-91. PMID:
17135275.
28. Goodman BK, Rutberg J, Lin WW, Pulver AE, Thomas GH. Hyperprolinaemia in patients with deletion (22)(q11.2) syndrome. J Inherit Metab Dis 2000;23:847-848. PMID:
11196113.
29. Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999;56:940-945. PMID:
10530637.
30. Pulver AE, Nestadt G, Goldberg R, Shprintzen RJ, Lamacz M, Wolyniec PS, et al. Psychotic illness in patients diagnosed with velo-cardiofacial syndrome and their relatives. J Nerv Ment Dis 1994;182:476-478. PMID:
8040660.
31. Shprintzen RJ, Goldberg R, Golding-Kushner KJ, Marion RW. Lateonset psychosis in the velo-cardio-facial syndrome. Am J Med Genet 1992;42:141-142. PMID:
1308357.
32. Bjerkenstedt L, Edman G, Hagenfeldt L, Sedvall G, Wiesel FA. Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls. Br J Psychiatry 1985;147:276-282. PMID:
2415198.
33. Wei J, Xu H, Ramchand CN, Hemmings GP. Low concentrations of serum tyrosine in neuroleptic-free schizophrenics with an early onset. Schizophr Res 1995;14:257-260. PMID:
7766538.
34. Reveley MA, De Belleroche J, Recordati A, Hirsch SR. Increased CSF amino acids and ventricular enlargement in schizophrenia: a preliminary study. Biol Psychiatry 1987;22:413-420. PMID:
3567257.
35. van der Heijden FM, Fekkes D, Tuinier S, Sijben AE, Kahn RS, Verhoeven WM. Amino acids in schizophrenia: evidence for lower tryptophan availability during treatment with atypical antipsychotics. J Neural Transm 2005;112:577-585. PMID:
15372327.
36. Fekkes D, Pepplinkhuizen L, Verheij R, Bruinvels J. Abnormal plasma levels of serine, methionine, and taurine in transient acute polymorphic psychosis. Psychiatry Res 1994;51:11-18. PMID:
8197268.
37. Muntjewerff JW, Kahn RS, Blom HJ, den Heijer M. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol Psychiatry 2006;11:143-149. PMID:
16172608.
38. First MB, Gibbon M, Robert LS, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders- Clinical Version (SCID-CV). 1997,Washington: American Press; p. 18